OR WAIT null SECS
November 25, 2019
The acquisition of The Medicines Company and its investigational cholesterol-lowering therapy extends Novartis’ cardiovascular pipeline.
November 20, 2019
Catalent has named Mike Grippo as the new senior vice president, Strategy and Corporate Development, and Julien Meissonnier as vice president and chief scientific officer.
November 14, 2019
With the gene-editing technology, Evotec will have the ability to accelerate research and enable the testing and development of new drugs.
October 24, 2019
The CPhI Pharma Index points to Germany as having consolidated itself into a leading pharma industry.
October 04, 2019
The companies are working together with Japanese clients to outline projects from early clinical stage up to commercial launch.
The new joint venture, named Oerth Bio, will use Arvinas’ Protac technology to develop innovative new agricultural products. As part of its collaboration with Arvinas, Bayer is also using this technology to develop human therapeutics.
October 01, 2019
New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.
September 06, 2019
A new report by GlobalData projects 2.9% growth by 2028 for the hemophilia A and B market across the eight major world markets.
September 04, 2019
Roche has extended its offering period for the purchase of Spark to provide US and UK regulatory authorities with additional time to complete their review of the acquisition.
Vertex will use the acquisition to develop cell-based treatments for type 1 diabetes.